IP Library Granted Patent US 7,517,345
Granted Patent B2
US 7,517,345 · App. 11/935,582 · Granted Apr 14, 2009

Surgical system and procedure for treatment of medically refractory atrial fibrillation

Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,517,345
App. No.
11/935,582
Granted
Apr 14, 2009
Kind
B2
Abstract

The invention provides surgical systems and methods for ablating heart tissue within the interior and/or exterior of the heart. A plurality of probes is provided with each probe configured for introduction into the chest for engaging the heart. Each probe includes an elongated shaft having an elongated ablating surface of a predetermined shape. The elongated shaft and the elongated ablating surface of each probe are configured to ablate a portion of the heart. A sealing device affixed to the heart tissue forms a hemostatic seal between the probe and the penetration in the heart to inhibit blood loss therethrough.

Claims (19)

1. A medical device for ablating tissue, the device comprising:

an elongate probe including a proximal end portion and a distal end portion at which the probe terminates, a cryogenic ablation surface disposed between the proximal end portion and the distal end portion closer to the distal end portion than the proximal end portion, and a malleable section overlapping at least a portion of the cryogenic ablation surface;

a flexible sheath, wherein the elongate probe is disposed at least partially within the flexible sheath such that moving the flexible sheath relative to the elongate probe adjusts an exposed length of the cryogenic ablation surface; and

a handle coupled to the proximal end portion of the elongate probe,

wherein the elongate probe can be selectively shaped to conform to a surface of cardiac tissue such that the cryogenic ablation surface can create a continuous lesion thereon.

2. The device according to claim 1 , wherein the probe is slidably disposed within the sheath.

3. The device according to claim 1 , wherein at least a portion of the cryogenic ablation surface overlaps a major portion of the malleable section.

4. A medical device for ablating tissue, the medical device comprising:

an elongate, linear probe including a proximal end portion, an intermediate portion, and a distal end portion;

a cryogenic ablation surface disposed upon the intermediate portion and proximate the distal end portion, and a malleable section between the proximal end portion and the distal end portion;

a flexible sheath, wherein the linear probe is disposed at least partially within the flexible sheath such that moving the flexible sheath relative to the linear probe adjusts an exposed length of the cryogenic ablation surface; and

a handle coupled to the proximal end portion of the linear probe,

wherein the linear probe is adapted to be selectively shaped to continuously conform to a surface of cardiac tissue and create a continuous lesion thereon.

5. A medical device for ablating tissue, the medical device comprising:

an elongate, linear probe body including a proximal end portion and a distal end portion;

a cryogenic ablation surface disposed between the proximal end portion and the distal end portion and disposed closer to the distal end portion than the proximal end portion, and a malleable section disposed between the proximal end portion and the distal end portion;

a flexible sheath, wherein the linear probe body is disposed at least partially within the flexible sheath such that moving the flexible sheath relative to the linear probe body adjusts an exposed length of the cryogenic ablation surface; and

a handle coupled to the proximal end portion of the linear probe body,

wherein the malleable section of the linear probe body can be selectively shaped via plastic deformation to continuously conform to a surface of cardiac tissue such that the ablation surface can create a continuous lesion thereon.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2011
From: HEARTPORT, INC.
To: EPICARDIA, INC.
Reel/Frame 026812/0233 →
CHANGE OF NAME Recorded Aug 26, 2011
From: EPICARDIA, INC.
To: EPICOR, INC.
Reel/Frame 026812/0673 →
CHANGE OF NAME Recorded Aug 26, 2011
From: EPICOR, INC.
To: EPICOR MEDICAL, INC.
Reel/Frame 026813/0250 →
MERGER Recorded Aug 26, 2011
From: EPICOR MEDICAL, INC.
To: ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC.
Reel/Frame 026814/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2011
From: COX, JAMES L., DR.; BOYD, STEPHEN W.; GIFFORD, III, HANSON S.; VASKA, MATTHIAS
To: HEARTPORT, INC.
Reel/Frame 026810/0139 →
Continuity (5)
Continuation 1017141100 · Jun 12, 2002
Continuation 0960674200 · Jun 29, 2000
Continuation 0894368300 · Oct 15, 1997
Continuation In Part 0873503600 · Oct 22, 1996
Related Publication 20080045935A1 · Feb 21, 2008